HLA-C and neoplasm: Today, these synthetic circuits are not restricted to extracellular antigens but can also be applied to recognize MHC-bound intracellular tumor-associated peptides, for instance via scFv fragments targeting specific peptide-MHC complexes fused to synNotch receptors for conditional activation (85).